Developer
Neckbolt Games: Revenue & Sales Estimates
Est. catalog lifetime net (USD): $276.6KRevenue estimates for the 7 Steam games developed by Neckbolt, ranked by estimated net revenue. Available estimated lifetime net (USD): $276.6K.
Catalog Est. Lifetime Net (USD)
$276.6K
Estimates for 5 of 7 tracked games
Tracked games
7
Top Earner
Belladonna
$127.1K
Coverage: 7 tracked titles; 5 with net estimates; 2 without. 2 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.
Role: Developer. These are lifetime estimates for games credited to Neckbolt; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.
Recorded release dates: 2015-02-27–2024-10-22 (may include announced dates).
Largest title accounts for 46.0% of available estimated net revenue. Coverage gaps can change this share.
Showing 1–7 of the top 7 displayed entries, from 7 tracked titles. Figures include only available estimates. Search the full catalog .
Rows 1–7 · Page 1 of 1
| # | Game | Est. lifetime net (USD) | Positive reviews (raw) | Release |
|---|---|---|---|---|
| 1 |  Belladonna | $127.1K | 72%Positive (776) | Feb 27, 2015 |
| 2 |  Yono and the Celestial Elephants | $120.7K | 83%Positive (344) | Oct 12, 2017 |
| 3 | Alruna and the Necro-Industrialists | $21.8K | 91%Positive (92) | Sep 26, 2024 |
| 4 | Molly Medusa: Queen of Spit | $4.7K | 70%Positive (10) | Sep 6, 2023 |
| 5 | October Panic | $2.2K | 96%Positive (26) | Oct 22, 2024 |
| 6 | Alruna: End of History | — | (0) | — |
| 7 | Let's Freeze Some Penguins | — | (0) | — |
Get real-time dashboards, historical trends, and AI-powered analysis
Explore on PlayRev(opens in new tab)Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.